Drug Profile, Targeted with Interpretation by Tandem Mass Spectrometry and Enzyme Immunoassay, Urine
Also known as: PAIN HYB 2
Use
This test is used to monitor medication compliance and detect undisclosed drug/substance use to support pain management and treatment of substance use disorders. It involves a qualitative analysis of urine samples using tandem mass spectrometry and enzyme immunoassay methods. Expert interpretation of the results is provided by clinical toxicologists.
Special Instructions
Not provided.
Limitations
This test does not differentiate between the delta-8 and delta-9 forms of THC or their metabolites. The absence of drugs or metabolites can indicate non-compliance, improper specimen collection timing, poor drug absorption, diluted/adulterated urine, or testing limitations. For confirmatory quantitative results, contact the laboratory within two weeks to request additional testing via a second analytical technique.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 2161-8 - Creat Ur-mCnc
- 3507-1 - Codeine Ur Ql
- 3830-7 - Morphine Ur Ql
- 10976-9 - 6MAM Ur Ql
- 10998-3 - oxyCODONE Ur Ql
- 61424-8 - Noroxycodone Ur Ql Cfm
- 11247-4 - oxyMORphone Ur Ql
- 89302-4 - Noroxymorphone Ur Ql Scn
- 12308-3 - HYDROcodone Ur Ql
- 61421-4 - Norhydrocodone Ur Ql Cfm
- 9834-3 - HYDROmorphone Ur Ql
- 3414-0 - Buprenorphine Ur Ql
- 58362-5 - Norbuprenorphine Ur Ql Cfm
- 11235-9 - fentaNYL Ur Ql
- 43199-9 - Norfentanyl Ur Ql
- 58388-0 - Normeperidine Ur Ql Cfm
- 72485-6 - Tapentadol Ur Ql Scn
- 3773-9 - Methadone Ur Ql
- 43219-5 - traMADol Ur Ql
- 19343-3 - Amphet Ur Ql Scn
- 3779-6 - Methamphet Ur Ql
- 14267-9 - MDMA Ur Ql
- 42253-5 - MDA Ur Ql
- 61048-5 - MDEA Ur Ql
- 3957-8 - Phentermine Ur Ql
- 12361-2 - Oxazepam Ur Ql
- 8435-5
- 9351-8 - Alpraz Ur Ql
- 61036-0 - A-OH Alpraz Ur Ql
- 19245-0 - clonazePAM Ur Ql
- 61030-3 - 7Aminoclonazepam Ur Ql
- 3550-1 - diazePAM Ur Ql
- 3861-2 - Nordiazepam Ur Ql
- 61059-2 - PPAA Spec Ql
- 61060-0 - Temazepam Ur Ql
- 18187-5 - LORazepam Ur Ql
- 19585-9 - Midazolam Ur Ql Scn
- 61045-9
- 61046-7
- 61047-3
- 8146-7
- 8935-9 - IO tube site
- 1264-7
- 2812-4
- 33411004
- 2261-8
- 6329-5
- 87715-3
- 87714-8
- 26822-3
- 2688-5
- 9291-8
- 19994-3 - O2/Total gas setting VFr Vent
- 1257-7
- 4612-8 - Hgb Malmo Bld Ql Elph Alk
- 1051-8
- 8005-7
- 87422-6
- 2571-8 - Trigl SerPl-mCnc
- 54118-6
- 7724-4
- 8920-0
- 9987-9 - R wave Amp L-AVR
- 2489-9
- 6068-2
- 1260-1
- 2224-6
- 3770-9
- 9388-0 - Propylthiouracil SerPl-mCnc
- 51022-0
- 2667-5
- 5094-3
- 61076-6 - EDDP Gast Ql
- 61075-1
- 4702-4
- 1270-3
- 61000-0
- 2799-9
- 6100-4
- 1261-9
- 3792-1
- 4931-3
- 3123-5
- 8444-5
- 2490-7
- 8274-2
- 6272-2
- 6345-9
- 5355-2
- 7215-3
- 9205-3
- 8101-9
- 11071-5
- 2160-0 - Creat SerPl-mCnc
- 3306-3
- 61000-3
- 8173-1
- 5140-4
- 4054-4
- 5620-3
- 61043-8
- 6177-0 - Aedes mosquito IgE Qn
- 61092-9
- 2718-4
- 41267-2
- 61041-9
- 1781-0
- 61000-1
- 3115-3 - URO-S Plas-cCnc
- 17806-0
- 3716-5
- 11307-1
- 6234-5
- 10291-2
- 71002-0
- 6948-9
- 2160-6
- 6084-1
- 1277-8
- 3213-7
- 19342-5 - Amobarbital CtO Ur Cfm-mCnc
- 5592-4
- 7565-9
- 5936-1
- 19806-4
- 3215-0
- 3214-2
- 3937-5
- 2802-5
- 5828-2
- 31554-4
- 2581-0
- 8210-8
- 1982-2
- 8276-7
- 2172-0
- 1786-6
- 26878-0
- 7623-0
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
4 mL in two transport tubes
Minimum Volume
2 mL each
Container
ARUP standard transport tubes with no additives or preservatives
Collection Instructions
Collect random urine.
Patient Preparation
Information on the patient's current medications must be submitted with the order. Include trade name, generic name, dosing frequency, and date of last dose, if known.
Causes for Rejection
Specimens exposed to repeated freeze/thaw cycles.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 1 month |
| Frozen | 1 month |
Other tests from different labs that may be relevant